Stephen Doster
-
Brenda Crews
With a heavy heart, we share that Brenda Crews, senior research specialist of the Marnett Lab in the Department of Biochemistry, has passed away. A loyal ‘Dore, Brenda was with Vanderbilt for more than 40 years, and a member of the Marnett lab for nearly 30 of those years! Lab… Read MoreJan. 19, 2022
-
The role of integrins in kidney “integrity”
Jan. 13, 2022, 10:40 AM by Bill Snyder Transmembrane receptors called integrins and proteins called laminins play important roles in the formation and function of tissues, including the ducts that collect urine from the filtering units of the kidneys. To better understand their role, Roy Zent,… Read MoreJan. 13, 2022
-
New Awards Announced for Postdoctoral Scholars in Biochemistry
By Dave Cortez and Aaron Conley The Department of Biochemistry at Vanderbilt University School of Medicine Basic Sciences announced new annual awards for postdoctoral scholars called the Destination Biochemistry Postdoctoral Scholar Awards. These awards will support exceptional postdoctoral fellows from around the world as they join labs in the Department… Read MoreJan. 10, 2022
-
Vanderbilt scientist’s team project wins $55,000 to research fundamental cell behavior
Lars Plate, assistant professor of chemistry and biological sciences, is on a team that won $55,000 from Scialog’s initiative, Chemical Machinery of the Cell. The award—one of 24 granted to 21 researchers in the U.S. and Canada—will enable… Read MoreJan. 7, 2022
-
Study explores how bacteria become drug resistant
Researchers at Vanderbilt University and the University of Arizona have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Their findings, which were reported recently in the journal Nature Chemical Biology, will aid the search for inhibitors… Read MoreJan. 6, 2022
-
Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023
Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. The initial agreement was signed in November… Read MoreDec. 22, 2021
-
Study sets framework for precision surveillance of colorectal cancer
by Tom Wilemon A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14 in Cell, describes findings from a single-cell transcriptomic and imaging atlas… Read MoreDec. 17, 2021
-
Neutrons take a deep dive into water networks surrounding DNA
By Olivia Trani This article was originally published on the Oak Ridge National Laboratory website and was adapted with permission for publication at Vanderbilt University. Water plays several important roles within the human body, even affecting the DNA in our cells. The entire surface of a DNA… Read MoreDec. 17, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered last year at Vanderbilt University Medical Center (VUMC). A number of medical conditions result in immune compromise, from treatments for many cancers… Read MoreDec. 9, 2021
-
McLean elected as 2021 National Academy of Inventors Fellow
John McLean, Stevenson Professor of Chemistry, Stevenson Chair and the director of the Center for Innovative Technologies, has been elected a 2021 Fellow of the National Academy of Inventors… Read MoreDec. 8, 2021